ProPhase Labs Acquires Digital Covid Vaccination and Testing "Passport" Solution
30 mars 2021 17h10 HE | Source: ProPhase Labs, Inc.
New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue – Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events GARDEN CITY, NY, March...
ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time
GARDEN CITY, NY, March 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021...
ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations
09 févr. 2021 08h30 HE | Source: ProPhase Labs, Inc.
Company Integrates Spectrum Solutions™ SDNA-1000 Saliva Collection System for Advanced, Simultaneous Multi-Viral Detection of Infections and Viral Mutations GARDEN CITY, NY, Feb. 09, 2021 ...
ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
Company to Host Business Update Shareholder's Conference Call on February 10, 2021 at 11:00 a.m. Eastern Time GARDEN CITY, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:...
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
29 janv. 2021 08h30 HE | Source: ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...
ProPhase Labs, Inc. Announces Closing of Public Offering
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced...
ProPhase Labs Announces Pricing of Public Offering of Common Stock
GARDEN CITY, NY, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of an underwritten public...
ProPhase Labs Announces Proposed Public Offering of Common Stock
GARDEN CITY, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed...
ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time
Company Exceeding Near Term Goals & Expands 2021 Testing Capacity Surpasses Targeted $30 Net Profit Margin Per COVID-19 Test GARDEN CITY, NY, Jan. 11, 2021 (GLOBE NEWSWIRE) -- ProPhase...
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive...
keyboard_arrow_left Page précédente
Page suivante keyboard_arrow_right